| 17-May-13 01:04PM | PROTALIX BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 14-May-13 10:28AM | Protalix Bio gets vote of confidence optionMONSTER |
| 09-May-13 10:16AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08-May-13 07:30AM | Protalix BioTherapeutics to Present at the Oppenheimer 14th Annual Israeli Conference GlobeNewswire |
| 01-May-13 11:10AM | Boris Peaker, Executive Director and Senior Analyst at Oppenheimer & Co. Inc., Interviews with The Wall Street Transcript: Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan Drugs Wall Street Transcript |
| 29-Apr-13 11:04AM | J.C. Penney Lands a Loan, Protalix Rides on Approval, and 3 Other Hot Stocks at Wall St. Cheat Sheet |
| 07:31AM | InPlay: Protalix BioTherapeutics: UPLYSO approved in Mexico and Chile for the treatment of Gaucher Disease Briefing.com |
| 07:30AM | UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease GlobeNewswire |
| 12:35AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 04-Apr-13 03:51PM | Update on Protalix Gaucher Study Zacks |
| 01:53PM | 5 Stocks Under $10 Set to Soar at TheStreet |
| 02-Apr-13 07:32AM | Protalix treats first Gaucher patient in Phase I study with PRX-112 theflyonthewall.com |
| 07:30AM | Protalix BioTherapeutics Treats First Gaucher Patient in Phase I Study With PRX-112, an Orally-Administered Enzyme Treatment of Gaucher Disease GlobeNewswire |
| 12:44AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 21-Mar-13 09:18AM | Brazil Approves Pfizer-Protalix Gaucher Drug Zacks |
| 18-Mar-13 02:15PM | UPLYSO(TM) (alfataliglicerase) Approved in Brazil by ANVISA for the Treatment of Gaucher Disease GlobeNewswire |
| 08:19AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 07-Mar-13 09:21AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 08:46AM | InPlay: Protalix BioTherapeutics Receives Approval to Initiate Phase I Study in Gaucher Patients With PRX-112, an Orally-Administered Candidate for the Treatment of Gaucher Disease Briefing.com |
| 08:46AM | InPlay: Protalix BioTherapeutics receives approval to initiate phase i study in gaucher patients With PRX-112, an orally-administered candidate for the treatment of Gaucher disease Briefing.com |
| 08:45AM | Protalix BioTherapeutics Receives Approval to Initiate Phase I Study in Gaucher Patients With PRX-112, an Orally-Administered Candidate for the Treatment of Gaucher Disease GlobeNewswire |
| 06-Mar-13 01:04PM | PROTALIX BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 28-Feb-13 04:33PM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 22-Feb-13 02:31PM | Special Protocol Assessments: The Case Studies at Seeking Alpha |
| 19-Feb-13 10:30AM | BioMarin Earnings: An Early Look at Motley Fool |
| 13-Feb-13 07:35AM | InPlay: Protalix BioTherapeutics announces new clinical data on ELELYSO to be presented at the WORLD Symposium 2013; data 'further reinforce the use of ELELYSO as a treatment option for Gaucher patients, including naive Gaucher patients, an Briefing.com |
| 07:33AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 07:30AM | Protalix Announces New Clinical Data on ELELYSO(TM) to be Presented at the WORLD Symposium 2013 GlobeNewswire |
| 09-Feb-13 12:03PM | This Week in Biotech at Motley Fool |
| 07-Feb-13 05:43PM | Protalix Exploring Options Zacks |
| 08:20AM | Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand Marketwire |
| 06-Feb-13 01:14PM | Who's Going to Buy This Orphan Drugmaker? at Motley Fool |
| 05-Feb-13 08:07PM | 4 Healthcare Stock Stories to Invite Wellness at Wall St. Cheat Sheet +14.74% |
| 04:02PM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online |
| 03:28PM | Dells Huge News and 4 Hot Stocks Moving Markets Now at Wall St. Cheat Sheet |
| 03:14PM | Why Protalix BioTherapeutics Shares Soared at Motley Fool |
| 01:56PM | Tuesday Options Brief: PBR, PLX & XLF at Seeking Alpha |
| 11:45AM | InPlay: Protalix BioTherapeutics reviewing partnering and other alternatives (see 9:07) Briefing.com |
| 11:43AM | Protalix BioTherapeutics Reviewing Partnering and Other Alternatives GlobeNewswire |
| 09:47AM | Protalix rallies following report of takeover talks theflyonthewall.com |
| 09:26AM | Pfizer's offer for Protalix below asking price, Calcalist reports theflyonthewall.com |
| 09:13AM | Pfizer expressed interest in acquiring Protalixm, Calcalist reports theflyonthewall.com |
| 07:30AM | Protalix BioTherapeutics to Present at the 15th Annual BIO CEO & Investor Conference GlobeNewswire |
| 31-Jan-13 07:30AM | Protalix BioTherapeutics Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium GlobeNewswire |
| 15-Jan-13 06:42PM | CAPScall of the Week: Amicus Therapeutics at Motley Fool |
| 11-Dec-12 12:56AM | Pfizer & Bristol-Myers Squibbs Eliquis Successful, Protalix Treats 1st Fabry Patient: Healthcare Biz Recap at Wall St. Cheat Sheet |
| 10-Dec-12 02:56PM | Pfizer & Bristol-Myers Squibbs Eliquis Successful, Protalix Treats 1st Fabry Patient: Healthcare Biz Recap at Wall St. Cheat Sheet |
| 06:03AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 02:00AM | Protalix BioTherapeutics Announces First Patient Treated in Phase I/II Study of Fabry Patients With PRX-102 GlobeNewswire |
| 06-Dec-12 07:10PM | Derma Sciences Prices Offering, Pfizer Partners with Protalix: Healthcare Business Wrap at Wall St. Cheat Sheet |
| 05:50PM | Derma Sciences Prices Offering, Pfizer Partners with Protalix: Healthcare Business Wrap at Wall St. Cheat Sheet |
| 05:44PM | Protalix extends Gaucher drug deal with Pfizer AP |
| 05:28PM | InPlay from Briefing.com Briefing.com |
| 04:55PM | InPlay from Briefing.com Briefing.com |
| 04:16PM | InPlay from Briefing.com Briefing.com |
| 03:43PM | InPlay from Briefing.com Briefing.com |
| 03:01PM | InPlay from Briefing.com Briefing.com |
| 01:34PM | InPlay from Briefing.com Briefing.com |
| 12:50PM | InPlay from Briefing.com Briefing.com |
| 10:55AM | InPlay from Briefing.com Briefing.com |
| 10:09AM | InPlay from Briefing.com Briefing.com |
| 09:39AM | InPlay from Briefing.com Briefing.com |
| 09:02AM | InPlay from Briefing.com Briefing.com |
| 08:29AM | InPlay from Briefing.com Briefing.com |
| 07:51AM | InPlay from Briefing.com Briefing.com |
| 07:51AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 07:45AM | InPlay: Protalix BioTherapeutics signs clinical development agreement with Pfizer for ELELYSO (taliglucerase alfa) Briefing.com |
| 07:44AM | Protalix BioTherapeutics Signs Clinical Development Agreement With Pfizer for ELELYSO(TM) (taliglucerase alfa) GlobeNewswire |
| 05-Dec-12 02:00AM | Protalix BioTherapeutics to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York City GlobeNewswire |
| 15-Nov-12 03:14AM | Protalix Bio gets vote of confidence optionMONSTER |
| 14-Nov-12 01:04PM | PROTALIX BIOTHERAPEUTICS, INC. Financials EDGAR Online Financials |
| 13-Nov-12 05:52PM | 4 Plays Under $10 on the Rise at TheStreet +8.81% |
| 08-Nov-12 09:29AM | Protalix BioTherapeutics to Present at the 2012 Jefferies Global Healthcare Conference in London GlobeNewswire |
| 07-Nov-12 04:07PM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 01-Nov-12 12:07PM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online +5.59% |
| 10:33AM | European Commission Issues Decision on Taliglucerase Alfa Marketing Authorization Application GlobeNewswire |
| 05-Oct-12 10:10AM | Good News, Just Not 13%-Pop Good News at Motley Fool |
| 04-Oct-12 02:18PM | 1 Rare Disease With an Array of Drugs at Motley Fool |
| 03-Oct-12 07:15AM | 1 Big Pharma That's Not Waving the White Flag at Motley Fool |
| 07:14AM | Opko Health: Setting Up For A Big Short Squeeze? Thomson Reuters ONE |
| 01-Oct-12 10:23AM | Protalix Biotherapeutics: Eyes On Elelyso Sales And Advancing Pipeline at Seeking Alpha |
| 30-Sep-12 01:31PM | A Home Run Drug in the Holy Land at Motley Fool |
| 29-Sep-12 05:51AM | A Home Run Drug in the Holy Land at Motley Fool |
| 28-Sep-12 06:09PM | A Home Run Drug in the Holy Land at Motley Fool |
| 02:29PM | A Home Run Drug in the Holy Land at Motley Fool |
| 01:32PM | A Home Run Drug in the Holy Land at Motley Fool |
| 27-Sep-12 06:41AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 06:32AM | Protalix receives marketing authorization for Elelyso from Israel theflyonthewall.com |
| 06:30AM | Protalix BioTherapeutics Receives Marketing Authorization for Elelyso(TM) for the Treatment of Gaucher Disease From the Israeli Ministry of Health GlobeNewswire |
| 20-Sep-12 03:05PM | Hedge Funds Love These 4 High-Growth Stocks Under $5 at Seeking Alpha |
| 19-Sep-12 01:21PM | 5 Superball Stocks at Motley Fool |
| 12-Sep-12 02:02PM | Is Protalix BioTherapeutics the Perfect Stock? at Motley Fool |
| 02:00AM | Protalix BioTherapeutics to Present at the UBS Global Life Sciences Conference GlobeNewswire |
| 05-Sep-12 03:58PM | Pfizer Adds to Orphan Drug Momentum at Motley Fool |
| 27-Aug-12 04:14PM | 5 Highly Liquid Biotech Stocks Positively Correlated To Volatility at Seeking Alpha |
| 24-Aug-12 10:19AM | Equity Briefing: Upgrades and Downgrades for August 24th: MCRS, MCRS, MDR, MENT, MMS, MRK, MSFT, NKE, ONTY Thomson Reuters ONE |
| 06:16AM | Protalix initiated with a Hold at Jefferies theflyonthewall.com |
| 23-Aug-12 04:58PM | 6 Cash-Heavy Biotech Stocks With Analyst Endorsements at Seeking Alpha |
| 13-Aug-12 07:33AM | PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 07:31AM | InPlay: Protalix BioTherapeutics receives FDA IND clearance to initiate a phase I/II study of fabry disease patients with PRX-102, a modified enzyme replacement therapy Briefing.com |
